With Saudi American Holdings’ intention to acquire new wind power and renewable energy companies such as Sky Harvest Windpower Corp. (SKYH) , they will begin their pursuit of growing the operating procedures of green energy companies.
Stock Market
Recent approval of swine flu vaccine’s by top pharmaceutical companies GlaxoSmithKline (GSK), Novartis (NVS) and Baxter International (BAX) to help ease influenza pandemic.
Top pharmaceutical companies in conjunction with wealthy nations are to help prevent the spread of the swine flu virus in under developed nations.
Top pharmaceutical company Vanguard Pharmaceuticals has recently been expanding its operations into the Latin and South American Markets, with effects that could be beneficial for the distribution of a swine flu vaccine.
Top pharmaceutical sales company Vanguard Pharmaceuticals has the possibility of acquiring a sales contact for the recently developed swine flu vaccine.
With the Swine Flu Virus now a global pandemic and other top biotech companies developing a swine flu vaccine, Vanguard Pharmaceutical’s has been recruited to distribute and promote a natural alternative to these scientific solutions.
Top Biotech Company AVI BioPharma (AVII), which develops RNA-based treatments for diseases like the Ebola virus, muscular dystrophy and the influenza virus has risen in stock price recently.
The UK Department has reported significant drops in the level of swine flu cases in the UK. But with winter coming for the Northern Hemisphere, At risk groups have been reported as the first to receive swine flu vaccine.
Crucell NV is currently developing the only adjuvanted flu vaccine against the influenza virus licensed for all age groups but Crucell stock hasn’t match analyst expectations showing a 20% increase since April 2009.
With two forms of influenza vaccine, BioCryst Pharma has the potential to emerge as one of the world’s top biotech companies in the fight against the swine flu. BioCryst stock has increase 450% since April 2009 reaching the best swine flu stock performed: Novavax NVAX with a 500% plus during the same period.

